Pharma Journalist -

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in…
Read More...

argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced it will regain worldwide rights to its…
Read More...

Samyang Holdings signed an MOU to co-develop a vaccine for COVID-19 with “mCureX (CEO: Hong Sun-woo),” a subsidiary of a “OliX Pharmaceuticals (CEO: Lee Dong-ki),” a pharmaceutical…
Read More...

Biogen and Eisai, Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s…
Read More...

Ascletis Pharma Inc. announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to…
Read More...

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...

SMi Group reports: Just one week to go until the highly anticipated Pre-Filled Syringes Virtual Event – the online portal is now live to network with Following the success of the…
Read More...

SMi Group reports: Key microbiology speaker interviews released ahead of SMi’s 4th Annual Microbiology West Coast Conference, taking place in two weeks. SMi Group had the opportunity…
Read More...

Merck known as MSD outside the United States and Canada, announced it has completed the spinoff of Organon & Co. (Organon). “Today marks a significant milestone for both Merck…
Read More...

Bayer announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this acquisition, Bayer will obtain exclusive rights…
Read More...